Hunan Dajiaweikang Pharmaceutical IndustryLtd Dividends and Buybacks
Dividend criteria checks 1/6
Hunan Dajiaweikang Pharmaceutical IndustryLtd is a dividend paying company with a current yield of 0.34% that is well covered by earnings.
Key information
0.3%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 0.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.040 |
| Payout ratio | 17% |
Recent dividend and buyback updates
Recent updates
There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump
Oct 08
Optimistic Investors Push Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Shares Up 30% But Growth Is Lacking
May 09Market Might Still Lack Some Conviction On Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Even After 31% Share Price Boost
Mar 08Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 301126 has been paying a dividend for less than 10 years.
Growing Dividend: 301126's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Hunan Dajiaweikang Pharmaceutical IndustryLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (301126) | 0.3% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Healthcare) | 1.7% |
| Analyst forecast (301126) (up to 3 years) | n/a |
Notable Dividend: 301126's dividend (0.34%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 301126's dividend (0.34%) is low compared to the top 25% of dividend payers in the CN market (2.12%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (17.5%), 301126's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 301126 is paying a dividend but the company has no free cash flows.